Literature DB >> 21946261

Kinetic efficiency: the missing metric for enhancing compound quality?

Geoffrey A Holdgate1, Adrian L Gill.   

Abstract

The kinetics of ligand-target interactions have been recognised as being instrumental in dictating the efficacy of drug action. Increased focus on kinetic signatures in drug discovery has concincided with improvements in label free methodology for measuring kinetic parameters. Simultaneously, focus has also been applied to increasing the quality of compounds, in terms of their physicochemical properties. To facilitate this drive towards higher compound quality, metrics such as ligand efficiency and enthalpic efficiency have been employed. We propose another metric, kinetic efficiency, that may be used pragmatically to help identify those compounds displaying differentiated kinetic behaviour. The combination of these metrics has the potential to improve decision-making in drug discovery leading to higher quality compounds and series. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 21946261     DOI: 10.1016/j.drudis.2011.09.006

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  7 in total

1.  Ligand efficiency metrics considered harmful.

Authors:  Peter W Kenny; Andrei Leitão; Carlos A Montanari
Journal:  J Comput Aided Mol Des       Date:  2014-06-05       Impact factor: 3.686

Review 2.  Biophysics in drug discovery: impact, challenges and opportunities.

Authors:  Jean-Paul Renaud; Chun-Wa Chung; U Helena Danielson; Ursula Egner; Michael Hennig; Roderick E Hubbard; Herbert Nar
Journal:  Nat Rev Drug Discov       Date:  2016-08-12       Impact factor: 84.694

3.  Mutation in Abl kinase with altered drug-binding kinetics indicates a novel mechanism of imatinib resistance.

Authors:  Agatha Lyczek; Benedict-Tilman Berger; Aziz M Rangwala; YiTing Paung; Jessica Tom; Hannah Philipose; Jiaye Guo; Steven K Albanese; Matthew B Robers; Stefan Knapp; John D Chodera; Markus A Seeliger
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-16       Impact factor: 11.205

4.  Structure-kinetic relationship study of CDK8/CycC specific compounds.

Authors:  Elisabeth V Schneider; Jark Böttcher; Robert Huber; Klaus Maskos; Lars Neumann
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-29       Impact factor: 11.205

Review 5.  Application of optical biosensors in small-molecule screening activities.

Authors:  Stefan Geschwindner; Johan F Carlsson; Wolfgang Knecht
Journal:  Sensors (Basel)       Date:  2012-03-28       Impact factor: 3.576

6.  Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70.

Authors:  Matthew D Cheeseman; Isaac M Westwood; Olivier Barbeau; Martin Rowlands; Sarah Dobson; Alan M Jones; Fiona Jeganathan; Rosemary Burke; Nadia Kadi; Paul Workman; Ian Collins; Rob L M van Montfort; Keith Jones
Journal:  J Med Chem       Date:  2016-05-11       Impact factor: 7.446

7.  Single-molecule study of the CUG repeat-MBNL1 interaction and its inhibition by small molecules.

Authors:  Amin Haghighat Jahromi; Masayoshi Honda; Steven C Zimmerman; Maria Spies
Journal:  Nucleic Acids Res       Date:  2013-05-09       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.